|
Volumn 122, Issue 3, 2015, Pages 651-652
|
Spectral-domain optical coherence tomography in hydroxychloroquine retinopathy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HYDROXYCHLOROQUINE;
ANTIRHEUMATIC AGENT;
ADULT;
AGED;
COHORT ANALYSIS;
CONFERENCE PAPER;
CONTROLLED STUDY;
DIAGNOSTIC TEST ACCURACY STUDY;
EYE EXAMINATION;
EYE TOXICITY;
HUMAN;
MAJOR CLINICAL STUDY;
MEDICAL RECORD REVIEW;
OPTICAL COHERENCE TOMOGRAPHY DEVICE;
PIGMENT EPITHELIUM;
PREDICTIVE VALUE;
PREVALENCE;
PRIORITY JOURNAL;
RECEIVER OPERATING CHARACTERISTIC;
RETINAL THICKNESS;
RETINOPATHY;
RETROSPECTIVE STUDY;
SENSITIVITY AND SPECIFICITY;
SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY;
SURVIVAL RATE;
TREATMENT DURATION;
CHEMICALLY INDUCED;
MIDDLE AGED;
OPTICAL COHERENCE TOMOGRAPHY;
PROCEDURES;
RETINAL DISEASES;
RHEUMATIC DISEASES;
VERY ELDERLY;
YOUNG ADULT;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTIRHEUMATIC AGENTS;
HUMANS;
HYDROXYCHLOROQUINE;
MIDDLE AGED;
RETINAL DISEASES;
RHEUMATIC DISEASES;
SENSITIVITY AND SPECIFICITY;
TOMOGRAPHY, OPTICAL COHERENCE;
YOUNG ADULT;
|
EID: 84924118466
PISSN: 01616420
EISSN: 15494713
Source Type: Journal
DOI: 10.1016/j.ophtha.2014.10.015 Document Type: Conference Paper |
Times cited : (4)
|
References (5)
|